"Melanoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
| Descriptor ID |
D008545
|
| MeSH Number(s) |
C04.557.465.625.650.510 C04.557.580.625.650.510 C04.557.665.510
|
| Concept/Terms |
Melanoma- Melanoma
- Melanomas
- Malignant Melanoma
- Malignant Melanomas
- Melanoma, Malignant
- Melanomas, Malignant
|
Below are MeSH descriptors whose meaning is more general than "Melanoma".
Below are MeSH descriptors whose meaning is more specific than "Melanoma".
This graph shows the total number of publications written about "Melanoma" by people in this website by year, and whether "Melanoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 6 | 1 | 7 |
| 1996 | 4 | 1 | 5 |
| 1997 | 1 | 0 | 1 |
| 1998 | 3 | 0 | 3 |
| 1999 | 9 | 1 | 10 |
| 2000 | 5 | 0 | 5 |
| 2001 | 5 | 1 | 6 |
| 2002 | 5 | 2 | 7 |
| 2003 | 4 | 0 | 4 |
| 2004 | 9 | 1 | 10 |
| 2005 | 6 | 4 | 10 |
| 2006 | 12 | 0 | 12 |
| 2007 | 5 | 2 | 7 |
| 2008 | 10 | 2 | 12 |
| 2009 | 11 | 1 | 12 |
| 2010 | 9 | 2 | 11 |
| 2011 | 11 | 2 | 13 |
| 2012 | 18 | 2 | 20 |
| 2013 | 17 | 2 | 19 |
| 2014 | 14 | 2 | 16 |
| 2015 | 18 | 2 | 20 |
| 2016 | 15 | 0 | 15 |
| 2017 | 19 | 1 | 20 |
| 2018 | 15 | 0 | 15 |
| 2019 | 19 | 1 | 20 |
| 2020 | 12 | 2 | 14 |
| 2021 | 13 | 3 | 16 |
| 2022 | 10 | 0 | 10 |
| 2023 | 17 | 0 | 17 |
| 2024 | 12 | 2 | 14 |
| 2025 | 6 | 0 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Melanoma" by people in Profiles.
-
Review of Non-Invasive Imaging Technologies for Cutaneous Melanoma. Biosensors (Basel). 2025 May 07; 15(5).
-
Comprehensive Profiling of Acral Lentiginous Melanoma Reveals Downregulated Immune Activation Compared to Cutaneous Melanoma. Pigment Cell Melanoma Res. 2025 May; 38(3):e70027.
-
PKCd Germline Variants and Genetic Deletion in Mice Augment Antitumor Immunity through Regulation of Myeloid Cells. Cancer Immunol Res. 2025 Apr 02; 13(4):547-559.
-
External validation of a model to predict recurrence-free and melanoma-specific survival for patients with melanoma after sentinel node biopsy. Br J Surg. 2025 Mar 28; 112(4).
-
Identification of Predictive Factors for the Development of In-Transit Metastasis in Patients with Melanoma. Ann Surg Oncol. 2025 May; 32(5):3203-3211.
-
Prognostic Value of Nevus-Associated Melanoma in Patients with Melanoma. Ann Surg Oncol. 2025 May; 32(5):3189-3197.
-
Impact of steroid-sparing immunosuppressive agents on tumor outcome in the context of cancer immunotherapy with highlight on melanoma: a systematic literature review and meta-analysis. Front Immunol. 2024; 15:1499478.
-
Society of Surgical Oncology Consensus Statement: Assessing the Evidence for and Utility of Gene Expression Profiling of Primary Cutaneous Melanoma. Ann Surg Oncol. 2025 Mar; 32(3):1429-1442.
-
The impact of demographics and socioeconomic status on the receipt of immunotherapy for stage III melanoma. Surg Oncol. 2024 Dec; 57:102156.
-
NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs. Cancer Immunol Res. 2024 Oct 01; 12(10):1421-1437.